n 505A(e)(1) of the Act, as amended  by FDAAA (Pub. L. No. 110-85), the following list identifies those approved drugs  for which a pediatric exclusivity determination was made, on or after September  27, 2007. &nbsp;In addition, it provides a  link to a copy of the Written Request&nbsp;and any amendments.</p>
          
           <p>NOTE: Only applications held by the identified  sponsor were granted pediatric exclusivity. We will update this page each time a determination  is made.</p>
           <p>T